New York Life Investment Management LLC Passage Bio, Inc. Transaction History

New York Life Investment Management LLC

  • $9.63 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
BUY
$1.06 - $1.48 $21,854 - $30,513
20,617 Added 12.7%
182,978 $252,000
Q3 2022

Nov 10, 2022
BUY
$1.22 - $2.48 $14,553 - $29,583
11,929 Added 7.93%
162,361 $203,000
Q2 2022

Aug 12, 2022
BUY
$1.63 - $3.46 $245,204 - $520,494
150,432 New
150,432 $355,000

Others Institutions Holding PASG

# of Institutions
47
Shares Held
38.7M
Call Options Held
7.7K
Put Options Held
0
View Full List

About Passage BIO, Inc.

PASG Quotes by TradingView
  • Ticker PASG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,463,200
  • Market Cap $32.1M
  • Description
  • Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...
More about PASG
Track This Portfolio

Track New York Life Investment Management LLC Portfolio

Follow New York Life Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on New York Life Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email